Oxford Vacmedix announces collaboration to develop vaccine and diagnostic tests for Covid-19
Collaboration with the Nuffield Department of Medicine, University of Oxford will use recombinant overlapping peptide technology to develop a novel vaccine and diagnostic tests for Covid-19